phase 1_completion
savePSI CRO AG — efanesoctocog alfa (Phase I Trial Completion)
community read0 votes
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)